Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology, Clinical Diagnosis Track

  • You have access
    Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
    Laure Michaud, Suzanne Kossatz, Anuradha Gopalan, Dmitry Yarilin, Serge Lyashchenko, Hedvig Hricak, vargas alvarez hebert alberto, Katia Manova, Touijer Karim and Wolfgang Weber
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 89;
  • You have access
    Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
    Palaniswamy Shanmuga Sundaram and Subramanyam Padma
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 398;
  • You have access
    Proton Range Verification with PET Imaging in Brain and Head and Neck Cancers
    Kira Grogg, Xuping Zhu, Helen Shih, Nathaniel Alpert and Georges El Fakhri
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 658;
  • You have access
    Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
    Chengfang Shangguan, Guifang Gan, Jieying Zhang, Jinliang Wu, Ying Miao, Miao Zhang, Biao Li and Jun Mi
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 349;
  • You have access
    Clinical Experience with 18F-fluciclovine (Axumin) in Prostate Cancer Patients with a Rising PSA After Primary Treatment
    Mitchel Muhleman, Julio Chong, Jalal Ahmed, Richard Stock, Ashutosh Tewari, John Doucette, William Oh and Lale Kostakoglu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1487;
  • You have access
    Ms
    Carrie Minnaar, Olusegun Akinwale Ayeni and Mboyo Vangu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 396;
  • You have access
    Metabolic Tumor Control Probability vs. absorbed dose in the Selective Internal Radiation Therapy of liver metastases with resin 90Y-microspheres
    Marta Cremonesi, Mahila Ferrari, Francesca Botta, Francesco Guerriero, Cristina Garibaldi, Marzia Colandrea, Chiara Grana, Guido Bonomo and Franco Orsi
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1378;
  • You have access
    Yttrium-90 imaging with Digital Photon Counting PET/CT: An intra-individual comparison with conventional photomultiplier tube-based PET/CT following radioembolization
    Chadwick Wright, Katherine Binzel, Jun Zhang, Evan Wuthrick, Eric Miller and Michael Knopp
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 600;
  • You have access
    Accuracy of Prediction for Y-90 Glass Microsphere Radioembolization in Hepatocellular Carcinoma Using IntrahepaticTc-99m MAA planning SPECT/CT
    Sherif Heiba, Somali Gavane, Abbas Tuli, Hossein Mehdikhani, Yasir Ahmad, Karin Knesaurek, Edward Kim and Lale Kostakoglu
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 1377;
  • You have access
    Positron Emission Mammography in management of new diagnosed breast cancer routine management
    Levent Guner, Kemal Unal, Burcin Tutar, Halil Kara, Gul Esen Icten, Cihan Uras and Erkan Vardareli
    Journal of Nuclear Medicine May 1, 2018, 59 (supplement 1) 415;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 51
SNMMI

© 2025 SNMMI

Powered by HighWire